1
|
Sun XH, Chai YH, Bai XT, Li HX, Xi YM. Pharmacology, medical uses, and clinical translational challenges of Saikosaponin A: A review. Heliyon 2024; 10:e40427. [PMID: 39641011 PMCID: PMC11617869 DOI: 10.1016/j.heliyon.2024.e40427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2024] [Revised: 11/08/2024] [Accepted: 11/13/2024] [Indexed: 12/07/2024] Open
Abstract
Saikosaponin A (SSA), the primary active monomer derived from the Radix bupleuri, demonstrates a diverse array of pharmacological activities, including anti-inflammatory, antitumor, analgesic, anti-fibrotic, antidepressant, and immune-modulating properties. Despite its potential therapeutic impact on various human diseases, comprehensive studies exploring SSA's efficacy in these contexts remain limited. This review synthesizes the current research landscape regarding SSA's therapeutic applications across different diseases, highlighting critical insights to overcome existing limitations and clinical challenges. The findings underscore the importance of further investigations into SSA's mechanisms of action, facilitating the development of targeted therapeutic strategies and their translation into clinical practice.
Collapse
Affiliation(s)
- Xiao-Hong Sun
- The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China
| | - Yi-Hong Chai
- The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China
| | - Xiao-Teng Bai
- The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China
| | - Hong-Xing Li
- The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China
| | - Ya-Ming Xi
- Division of Hematology, The First Hospital of Lanzhou University, Lanzhou, 730000, China
| |
Collapse
|
2
|
Ismaiah MJ, Lau KT, Tsui JSJ, Johnson-Hill WA, Leung KS, Lee JCY. Continuous step-wise temperature extraction improves the flavanol content of tea beverages. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE 2024. [PMID: 39543852 DOI: 10.1002/jsfa.14035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 11/04/2024] [Accepted: 11/04/2024] [Indexed: 11/17/2024]
Abstract
BACKGROUND Tea is the second most consumed beverage worldwide and its health benefits have been extensively studied because of its rich flavanol content. This study aims to evaluate the efficacy of a novel continuous step-wise temperature extraction process in maximising antioxidant activity, total phenolic content and flavanol concentration of different tea beverages. RESULTS Continuous step-wise temperature extraction produced the highest absolute antioxidant capacity, total phenolic content and concentration of major tea flavanols in Yuhua tea compared to the other tea types at all extraction points. Despite having the lowest baseline concentration of tea flavanols, Lapsang Souchong tea showed the greatest increase in catechin and epigallocatechin-3-gallate levels with the continuous step-down temperature process, by over 500% and 300%, respectively. In addition, Moonlight White tea showed the greatest percentage change in total antioxidant capacity and phenolic content at the end of the process compared to the baseline. Furthermore, the continuous step-wise temperature extraction showed a moderate increase in caffeine concentration in all the tea samples. CONCLUSION Our findings revealed a beneficial impact of continuous step-wise temperature extraction on the antioxidant capacity, phenolic content and flavanol profile in different types of tea, which may be valuable in the production of added-value tea beverages. © 2024 Society of Chemical Industry.
Collapse
Affiliation(s)
| | - Kin Tak Lau
- School of Biological Sciences, The University of Hong Kong, Hong Kong, Hong Kong SAR
| | - Jacob Shing-Jie Tsui
- School of Biological Sciences, The University of Hong Kong, Hong Kong, Hong Kong SAR
| | | | - Kin Sum Leung
- School of Biological Sciences, The University of Hong Kong, Hong Kong, Hong Kong SAR
| | - Jetty Chung-Yung Lee
- School of Biological Sciences, The University of Hong Kong, Hong Kong, Hong Kong SAR
| |
Collapse
|
3
|
Mazzola G, Rondanelli M, Baron G, Zupo R, Castellana F, Clodoveo ML, Gasparri C, Barrile GC, Seniga M, Schiavi LM, Moroni A, Gulec S, Riso P, Perna S. Bergamot ( Citrus bergamia), a (Poly)Phenol-Rich Source for Improving Osteosarcopenic Obesity: A Systematic Review. Foods 2024; 13:3422. [PMID: 39517207 PMCID: PMC11545342 DOI: 10.3390/foods13213422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2024] [Revised: 10/22/2024] [Accepted: 10/23/2024] [Indexed: 11/16/2024] Open
Abstract
This systematic review investigates the potential of bergamot, a polyphenol-rich citrus fruit, in improving osteosarcopenic obesity, a condition characterized by the simultaneous presence of osteoporosis, obesity, and sarcopenia. Bergamot extracts have been suggested to possess several pharmacological properties, including anti-inflammatory and antioxidant effects, which could be useful in the management of age-related diseases and neuromuscular health. The review highlights the promising effects of bergamot extracts on skeletal muscle mass and function, particularly in the context of obesity, metabolic syndrome, osteosarcopenic obesity, and osteoporosis. Furthermore, some studies have shown that bergamot extracts can improve the metabolic balance, endothelial function, and maximal oxygen uptake in athletes, highlighting their potential benefits for skeletal muscle health. Taken together, these results suggest that bergamot extracts, especially those rich in polyphenols, may be a valuable adjunct in the management of osteosarcopenic obesity and other associated clinical conditions involving pro-inflammatory effects on organs and tissues.
Collapse
Affiliation(s)
- Giuseppe Mazzola
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona “Istituto Santa Margherita”, University of Pavia, 27100 Pavia, Italy; (C.G.); (G.C.B.); (M.S.); (L.M.S.); (A.M.)
| | - Mariangela Rondanelli
- Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy;
| | - Giovanna Baron
- Department of Pharmaceutical Sciences (DISFARM), University of Milan, Via Mangiagalli 25, 20133 Milan, Italy;
| | - Roberta Zupo
- Department of Interdisciplinari Medicine, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70100 Bari, Italy; (R.Z.); (M.L.C.)
| | - Fabio Castellana
- Department of Interdisciplinari Medicine, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70100 Bari, Italy; (R.Z.); (M.L.C.)
| | - Maria Lisa Clodoveo
- Department of Interdisciplinari Medicine, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70100 Bari, Italy; (R.Z.); (M.L.C.)
| | - Clara Gasparri
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona “Istituto Santa Margherita”, University of Pavia, 27100 Pavia, Italy; (C.G.); (G.C.B.); (M.S.); (L.M.S.); (A.M.)
| | - Gaetan Claude Barrile
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona “Istituto Santa Margherita”, University of Pavia, 27100 Pavia, Italy; (C.G.); (G.C.B.); (M.S.); (L.M.S.); (A.M.)
| | - Michela Seniga
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona “Istituto Santa Margherita”, University of Pavia, 27100 Pavia, Italy; (C.G.); (G.C.B.); (M.S.); (L.M.S.); (A.M.)
| | - Luca Matteo Schiavi
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona “Istituto Santa Margherita”, University of Pavia, 27100 Pavia, Italy; (C.G.); (G.C.B.); (M.S.); (L.M.S.); (A.M.)
| | - Alessia Moroni
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona “Istituto Santa Margherita”, University of Pavia, 27100 Pavia, Italy; (C.G.); (G.C.B.); (M.S.); (L.M.S.); (A.M.)
| | - Sukru Gulec
- Molecular Nutrition and Human Physiology Laboratory, Department of Food Engineering, Faculty of Engineering, İzmir Institute of Technology, Urla, 35430 Izmir, Türkiye;
| | - Patrizia Riso
- Department of Food, Environmental and Nutritional Sciences, Division of Human Nutrition, University of Milan, 20133 Milan, Italy; (P.R.); (S.P.)
| | - Simone Perna
- Department of Food, Environmental and Nutritional Sciences, Division of Human Nutrition, University of Milan, 20133 Milan, Italy; (P.R.); (S.P.)
| |
Collapse
|
4
|
Chen T, Qin X, Jiang J, He B. Diagnostic indicators and lifestyle interventions of metabolic-associated fatty liver disease. Front Nutr 2024; 11:1424246. [PMID: 38946789 PMCID: PMC11211376 DOI: 10.3389/fnut.2024.1424246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2024] [Accepted: 06/05/2024] [Indexed: 07/02/2024] Open
Abstract
MAFLD has become a major global health problem and is the leading cause of liver disease worldwide. The disease progresses from a simple fatty liver to gradual fibrosis, which progresses to cirrhosis and even hepatocellular liver cancer. However, the methods currently used for diagnosis are invasive and do not facilitate clinical assessment of the condition. As a result, research on markers for the diagnosis of MAFLD is increasing. In addition, there are no clinical medications for the treatment of MAFLD, and lifestyle interventions remain effective in the prevention and treatment of MAFLD. In this review, we attempt to make a summary of the emerging diagnostic indicators and effective lifestyle interventions for MAFLD and to provide new insights into the diagnosis and treatment of MAFLD.
Collapse
Affiliation(s)
- Tianzhu Chen
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
| | - Xiang Qin
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
| | - Jianping Jiang
- Hangzhou Lin’an Traditional Chinese Medicine Hospital, Affiliated Hospital, Hangzhou City University, Hangzhou, China
| | - Beihui He
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China
| |
Collapse
|
5
|
Cordeiro KC, Scaffo J, Flexa BN, Gama CCA, Ferreira MA, Cruz RAS, Aguiar-Alves F, Rocha L, Machado FP, Fernandes CP. Characterization of bergamot essential oil: chemical, microbiological and colloidal aspects. BRAZ J BIOL 2024; 83:e275622. [PMID: 38422264 DOI: 10.1590/1519-6984.275622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Accepted: 12/12/2023] [Indexed: 03/02/2024] Open
Abstract
Citrus bergamia is a citric species known as bergamot. The species is widely used due to its derivatives, such as juices, extracts, and essential oil. Specifically, the bergamot essential oil (BEO) is of great interest, with a chemical composition rich in terpenes and esters. Considering its chemical composition, bioactivity, and great economic potential, the characterization of BEO should be studied. However, this essential oil is almost unexplored in terms of a characterization associated with colloids. Chemical characterization was carried out by gas-chromatography coupled to a mass spectrometer and by gas-chromatography coupled to a flame ionization detector. Antibacterial activity against Staphylococcus aureus and Escherichia coli was carried out to confirm the bioactivity of this important essential oil. Dynamic light scattering analysis was performed to create a pattern of droplet size distribution of BEO. Major compounds of BEO were linalyl acetate, limonene, and linalool. The BEO was active against E. coli and presented a MIC value of 2.000 µg/mL, while values of MIC and MBC higher than 2.000 µg/mL were observed for S. aureus. The dynamic light scattering analysis revealed a mean hydrodynamic diameter of 65.7 ± 2.2 nm. After a 1:10 dilution it was observed reduction of mean diameter and enhancement of the percentagem of low size droplets, resepctively 44.1 ± 1.2 nm and 14.5 ± 0.5 nm (28.8 ± 1.2%). Higher droplets and reduced polydispersity index were observed after 1:100 dilution. In the present study, the chemical characterization was in accordance with the species, as the characteristic chemical markers of the species were found. Moreover, it has presented antibacterial activity as expected for the BEO. The analysis of the colloid showed a pattern of droplet size distribution following the Ostwald ripening mechanism after dilution.
Collapse
Affiliation(s)
- K C Cordeiro
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - J Scaffo
- Universidade Federal Fluminense - UFF, Laboratório de Epidemiologia Molecular e Biotecnologia, Niterói, RJ, Brasil
- Universidade Federal Fluminense - UFF, Programa de Pós-graduação em Ciências Aplicadas à Produtos para Saúde, Niterói, RJ, Brasil
| | - B N Flexa
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - C C A Gama
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - M A Ferreira
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - R A S Cruz
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - F Aguiar-Alves
- Universidade Federal Fluminense - UFF, Laboratório de Epidemiologia Molecular e Biotecnologia, Niterói, RJ, Brasil
- Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy, Department of Pharmaceutical Sciences, Florida, FL, United States
| | - L Rocha
- Universidade Federal Fluminense - UFF, Laboratório de Tecnologia de Produtos Naturais, Niterói, RJ, Brasil
| | - F P Machado
- Universidade Federal Fluminense - UFF, Laboratório de Tecnologia de Produtos Naturais, Niterói, RJ, Brasil
| | - C P Fernandes
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
- Universidade Federal Fluminense - UFF, Laboratório de Epidemiologia Molecular e Biotecnologia, Niterói, RJ, Brasil
| |
Collapse
|